Supply Issues Vygon UK Ltd Filter Endotoxin FTC225 (ICN 3408)

• The supplier Vygon UK Ltd has informed us that the supply issue with its filter endotoxin is continuing.
• One product code is affected in total:
  • FTC225 – Filter endotoxin Neonatal 96hr endotoxin 0.22 micron with needlefree access port below filter double connection site above filter anti reflux valves and clamps.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternative.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is anticipated to be resolved by 2 October 2026.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.

Change:

• The supplier Vygon UK Ltd has informed us of a supply issue with its filter endotoxin products.
• There is one product affected:
  • FTC225 – Filter endotoxin Neonatal 96hr endotoxin 0.22 micron with needlefree access port below filter double connection site above filter anti reflux valves and clamps.
• There is a production delay is due to repairs on the machinery used to manufacture the product.

Impact:

• FTC225 is available while our current stocks last. Once its depleted it will be unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 31 August 2026.

Next Steps:

• Customers are advised to log into our website to view the product listing for further information on the affected product code and potential alternatives.
• Alternatives linked are indirect so compatibility will need to be considered.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.